Drugs Made In America Acquisition Corp. (DMAAR) Debt Ratio (2024 - 2026)
Drugs Made In America Acquisition's (DMAAR) quarterly Debt Ratio came in at 0.0 in Q2 2026, up 355.41% quarter-over-quarter from 0.0 in Q1 2025.
Analysis
Drugs Made In America Acquisition Corp. (DMAAR) Debt Ratio (2024 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMAAR) has reported Debt Ratio for 3 consecutive years, with 0.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Debt Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Jun 2026 stood at 0.0 (changed N/A YoY), and the FY2024 full-year result was 2.4, changed N/A from the prior year.
- Debt Ratio rose to 0.0 in Q2 2026 per DMAAR's latest filing, from 0.0 in the prior quarter.
- Across five years, Debt Ratio topped out at 2.4 in Q4 2024 and bottomed at 0.0 in Q1 2025.
- Historically, Debt Ratio has averaged 0.8 across 3 years, with a median of 0.0 in 2026.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 2.40 |